Citadel Advisors »

Leap Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 476k 2.57
2024-06-30 $1.8M 928k 1.96
2024-03-31 $1.9M 729k 2.66
2023-12-31 $3.0M 721k 4.15
2023-09-30 $898k 651k 1.38
2023-06-30 $306k 98k 3.13